World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
70
Citations
28162
World Ranking
1397
National Ranking
708

Federico Mingozzi publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Federico Mingozzi sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 184 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Federico Mingozzi D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Federico Mingozzi sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 70 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Federico Mingozzi is affiliated with the University of Pennsylvania in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Genetics, Molecular Biology, Oncology, Hematology, and Physiology.

The scientist's work concentrates notably on virus-based gene therapy research, CAR-T cell therapy research, CRISPR and genetic engineering, hemophilia treatment and research, lysosomal storage disorders research, RNA interference and gene delivery, and glycogen storage diseases and myoclonus.

Frequent publication venues for Federico Mingozzi include:

  • Molecular Therapy
  • Molecular Therapy - Methods & Clinical Development
  • Blood
  • Human Gene Therapy
  • Frontiers in Immunology

Some of the recent papers authored or co-authored by Mingozzi are:

  • "AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer," 2020, Molecular Therapy
  • "Human Immune Responses to Adeno-Associated Virus (AAV) Vectors," 2020, Frontiers in Immunology
  • "IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies," 2020, Nature Medicine
  • "Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A," 2021, New England Journal of Medicine
  • "Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B," 2020, Molecular Therapy

Frequent collaborators in their research include:

  • Giuseppe Ronzitti
  • Fanny Collaud
  • Séverine Charles
  • Klaudia Kuranda
  • Christian Leborgne

Best Publications

  • Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    Albert M. Maguire;Francesca Simonelli;Eric A. Pierce;Edward N. Pugh

  • Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Manno Cs;Pierce Gf;Arruda Vr;Glader B

  • Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Amit C. Nathwani;Edward G.D. Tuddenham;Savita Rangarajan;Cecilia Rosales

  • Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

    Federico Mingozzi;Katherine A. High;Katherine A. High

  • Immune responses to AAV vectors: overcoming barriers to successful gene therapy

    Federico Mingozzi;Katherine A. High;Katherine A. High;Katherine A. High

  • Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    Albert M. Maguire;Albert M. Maguire;Katherine A. High;Katherine A. High;Alberto Auricchio;J. Fraser Wright;J. Fraser Wright

  • Emerging Issues in AAV-Mediated In Vivo Gene Therapy

    Pasqualina Colella;Giuseppe Ronzitti;Federico Mingozzi;Federico Mingozzi

  • CD8(+) T-cell responses to adeno-associated virus capsid in humans.

    Federico Mingozzi;Marcela V Maus;Marcela V Maus;Daniel J Hui;Denise E Sabatino

  • Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.

    Francesca Simonelli;Albert M Maguire;Albert M Maguire;Francesco Testa;Eric A Pierce

  • AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

    Helena Costa Verdera;Klaudia Kuranda;Federico Mingozzi

  • Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer

    Federico Mingozzi;Yi-Lin Liu;Eric Dobrzynski;Antje Kaufhold

  • Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    Jean Bennett;Jean Bennett;Jennifer Wellman;Kathleen A Marshall;Sarah McCague

  • AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

    Jean Bennett;Jean Bennett;Manzar Ashtari;Jennifer Wellman;Kathleen A. Marshall

  • Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy.

    Haiyan Jiang;Linda B. Couto;Susannah Patarroyo-White;Tongyao Liu

  • Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins.

    Amit C Nathwani;Amit C Nathwani;Cecilia Rosales;Jenny McIntosh;Ghasem Rastegarlari

  • AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells

    Federico Mingozzi;Janneke J. Meulenberg;Daniel J. Hui;Etiena Basner-Tschakarjan

  • High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

    E Ayuso;F Mingozzi;J Montane;X Leon

  • Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer

    Jeannette Bennicelli;John Fraser Wright;John Fraser Wright;Andras Komaromy;Jonathan B Jacobs

  • Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.

    Jenny McIntosh;Jenny McIntosh;Peter J. Lenting;Cecilia Rosales;Cecilia Rosales;Doyoung Lee

  • Assessing the potential for AAV vector genotoxicity in a murine model

    Hojun Li;Nirav Malani;Shari R. Hamilton;Alexander Schlachterman

Frequent Co-Authors

Olivier Benveniste
Olivier Benveniste Sorbonne University
Olivier Boyer
Olivier Boyer University of Rouen
Hildegard Büning
Hildegard Büning Hannover Medical School
Francesco Bernardi
Francesco Bernardi University of Ferrara
Henry J. Kaplan
Henry J. Kaplan University of Louisville
Constance L. Cepko
Constance L. Cepko Harvard University
Mark A. Kay
Mark A. Kay Stanford University
Alan H. Beggs
Alan H. Beggs Harvard Medical School
George M. Church
George M. Church Harvard University
Michio Hirano
Michio Hirano Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of molecular biology connects to a wide range of dynamic career paths and educational opportunities. Many students consider online degrees for greater flexibility, allowing them to balance studies with work or life commitments. For those interested in related STEM fields, a bsc mathematics online can complement molecular biology by strengthening analytical and quantitative skills valuable in research and data analysis.

If you are drawn to creativity and communication, a graphic design online degree offers tools to help visualize scientific ideas or build impactful presentations. Some may be interested in bridging molecular science with architecture; exploring online architecture programs could open opportunities in biotech facilities design and lab planning.

For professionals seeking a sector change, such as educators wanting to transition to healthcare, resources on career change for teachers provide helpful guidance. Ultimately, these diverse online degree options and career pathways can empower you to personalize your journey in molecular biology and beyond.

Best Scientists Citing Federico Mingozzi

Trending Scientists